iCoreConnect Inc. (Nasdaq: ICCT) is a healthcare technology company that completed its business combination with a special purpose acquisition company and began trading as a public entity in 2022. The company develops and markets cloud-based software solutions — including electronic prescribing, secure messaging, and insurance-eligibility verification tools — aimed primarily at dental and medical practices across the United States. Operating within the healthcare information technology sector, iCoreConnect filed a Form 8-K with the Securities and Exchange Commission on September 20, 2024, reflecting ongoing public-company reporting obligations following its de-SPAC transition. For comprehensive filing data, sponsor details, and deal history on iCoreConnect and hundreds of other SPAC transactions, sign up for full access at SpacDesk.